相关实验视频

Updated: May 11, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

通过有机金属化合物介导的内部和外部双重光疗剂,用于协作抗瘤治疗

Yibo An¹, Man Li², Pan He³

¹State Key Laboratory of Vaccines for Infectious Diseases & Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China; Sichuan Research Institute of Xiamen University, Chengdu, 610000, China.

|May 13, 2025

概括

这项研究引入了用于增强瘤治疗的新型-有机金属化合物 (IR-C6Ir). 这些化合物利用Cerenkov光激活进行优越的近红外光成像和光疗,显著减少瘤体积,毒性最小.

科学领域:

生物医学工程生物医学工程
材料科学材料科学材料科学
在瘤学瘤学.

背景情况:

与外部光源相比,Cerenkov光激发在光学成像和治疗中具有更深层次的组织透的潜力.
目前Cerenkov光强度和波长的局限性限制了其在瘤治疗学中的应用.
有机金属化合物为开发先进的治疗药物提供了多功能平台.

研究的目的:

通过将有机金属化合物与放射性核酸激活集成来开发一种新型的放射性光热剂.
为了实现放射性核素激活的近红外 (NIR) 光敏感度超过800nm,用于增强瘤成像和治疗.
设计一种双重功能剂,用于内部 (Cerenkov) 和外部光激活光疗法,具有协同效应.

主要方法:

通过通过来连接6和IR775衍生物,合成双重功能-有机金属化合物 (IR-C6Ir).
在瘤线粒体中IR-C6Ir积累的评估.
使用-18 (18F) 放射性核素和808nm激光照射的组合评估抗瘤疗效.
研究内部和外部光疗模式之间的协同效应.

主要成果:

IR-C6Ir化合物在瘤线粒体中显示出优先积累.
实现了显著的瘤抑制,在低度 (0.65μM) 和激发水平 (0.5W/cm2激光,800μCi 18F) 的情况下,瘤体积减少了92.5%.
双光疗方法表现出一种协同的"1+1>2"增强效应.
使用开发的药物成功实现了瘤多重可视化.

结论:

开发的IR-C6Ir代表了第一个以放射性核素激活的NIR光敏感剂,可在800nm以上运行.
创新的"内部-外部攻击"和"二合一"能量传输设计使高效,低毒性光疗成为可能.
这一策略为先进的瘤治疗学和多重成像提供了一个有希望的新途径.

关键词:

切伦科夫的灯光是为了照明.光动力学疗法是一种光动力学疗法.热浪学是什么意思热浪学

更多相关视频

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Published on: February 9, 2021

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.